Esperion Therapeutics: Of The Original Report To Present The Required Financial Statements And Pro Forma Financial Information Not Later Than 71 Calendar Days From The Date On Which The Original Report Was Required To Be Filed, As Permitted Under Items 9.01(a)(3) And 9.01(b)(2). Except For The Filing Of Such Financial Statements And Pro Forma Financial Information, This Amendment Does Not Otherwise Modify Or Update The Original Report, And This Amendment Should Be Read In Conjunction With The Original Report

Show full article

This functionality is available for registred users only

• Full name
  Esperion Therapeutics, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***